A major international study has found that heart patients, particularly seniors, may benefit more from newer blood-thinning medications called P2Y12 inhibitors than traditional aspirin therapy ...
Pretreatment with P2Y12 inhibitors is associated with a lower risk of MACE compared with giving these medications at the time of primary PCI, at least in those STEMI patients facing delays of greater ...
Long-term maintenance with P2Y12 inhibitor monotherapy after discontinuing dual antiplatelet therapy (DAPT) in patients who’ve undergone PCI seems to reduce MACCE compared with aspirin monotherapy ...
An appropriate duration of dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction that has been treated with guideline-recommended complete ...
Compared with those assigned to aspirin, patients assigned to a P2Y12 inhibitor had a lower net composite of adverse cardiac and cerebrovascular events. HealthDay News — For patients who undergo ...
NEW ORLEANS — Two new studies from Asia provide more evidence that extended monotherapy with clopidogrel (Plavix, Sanofi) or another P2Y12 inhibitor antiplatelet, rather than either dual antiplatelet ...
Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of cardiovascular death, heart attack and stroke compared with traditional aspirin, ...
Please provide your email address to receive an email when new articles are posted on . P2Y12 monotherapy after PCI was not as protective from ischemic events vs. DAPT with aspirin. Monotherapy did ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Two new Asian studies have shown that short durations of dual antiplatelet therapy (DAPT) followed by longer treatment with P2Y12 inhibitor monotherapy alone may be a safe and effective regimen for ...
MADRID -- Two trials looking into the need for 1 year of dual antiplatelet therapy (DAPT) after angioplasty for acute coronary syndrome (ACS) found patients couldn't do without it entirely. With early ...
Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of cardiovascular death, heart attack and stroke compared with traditional aspirin, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results